Emerging trends in pharmaceutical design and drug manufacturing are shifting toward presenting the market with new ways to develop medications. Specialty medications continue to be a major area of pharmaceutical development and have become widely discussed in workers’ comp due to their significant costs. Although they represent approximately 1% of drug utilization, they account for nearly 7% of prescription drug costs and represent the fastest-growing segment of the U.S. pharmaceutical market. While specialty drug products are often associated with a hefty price tag, some can offer clinical advantages when deployed for the right patient at the right time, making careful oversight and patient selection imperative to achieving desired outcomes in this space. Watch the video blog to learn more.
More stories
Mitchell
News Release
Mitchell’s Virtual Claims Workflow for the Connected Consumer
Today's connected consumers tend to have a higher expectation of self-service options.
PDF
Article
Virtual Connections
Mitchell
News Release
Industrial Commission of Arizona Adopts New Pharmacy and Physician Fee Schedules
The Industrial Commission of Arizona (ICA) recently posted the newly adopted pharmaceutical and physician fee schedules for 2019-2020.
Mitchell
News Release
Mitchell Issues 3rd Quarter 2019 Industry Trends Report
San Diego, CA—Mitchell Internati
Workers' Comp
Blog
Morphine Equivalent Dose (MED) Trends in 2018
Morphine Equivalent Dose (MED) remains a valuable indicator of risk when it comes to opioids, and we continue to see downward trends through 2018 that
Workers' Comp
News Release
Risk & Insurance: Better Recovery Outcomes Are Built on Trust, Says This Nurse Case Manager
British socialite-turned-nurse Floren